A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
Market Analysis and Insights: Global Continuous Glucose Monitoring Devices Market
The global Continuous Glucose Monitoring Devices market is projected to grow from US$ 4808.2 million in 2024 to US$ 5979.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.7% during the forecast period.
Global Continuous Glucose Monitoring Systems key players include Dexcom, Abbott Laboratories, Medtronic, etc. Global top three manufacturers hold a share about 95%.
North America is the largest market, with a share about 65%, followed by Europe and Asia-Pacific, both have a share about 30 percent.
In terms of product, Wearable is the largest segment, with a share about 99%. And in terms of application, the largest application is Adult, followed by Elderly.
Report Covers:
This report presents an overview of global market for Continuous Glucose Monitoring Devices market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Continuous Glucose Monitoring Devices, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Continuous Glucose Monitoring Devices, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Continuous Glucose Monitoring Devices revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Continuous Glucose Monitoring Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Continuous Glucose Monitoring Devices revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Abbott Laboratories
Echo Therapeutics, Inc.
Dexcom, Inc.
GlySens Incorporated
Medtronic plc
Senseonics Holdings, Inc.
Johnson & Johnson
F. Hoffmann-La Roche Ltd.
AgaMatrix, Inc.
Glucovation
GlySure
Arkray USA, Inc.
OrSense
Segment by Type
Sensors
Transmitters & Receivers
Insulin Pumps
Segment by Application
Diabetic Patients
Healthy Individuals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Continuous Glucose Monitoring Devices in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Continuous Glucose Monitoring Devices companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Continuous Glucose Monitoring Devices revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Continuous Glucose Monitoring Devices Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Sensors
1.2.3 Transmitters & Receivers
1.2.4 Insulin Pumps
1.3 Market by Application
1.3.1 Global Continuous Glucose Monitoring Devices Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Diabetic Patients
1.3.3 Healthy Individuals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Continuous Glucose Monitoring Devices Market Perspective (2019-2030)
2.2 Global Continuous Glucose Monitoring Devices Growth Trends by Region
2.2.1 Continuous Glucose Monitoring Devices Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Continuous Glucose Monitoring Devices Historic Market Size by Region (2019-2024)
2.2.3 Continuous Glucose Monitoring Devices Forecasted Market Size by Region (2025-2030)
2.3 Continuous Glucose Monitoring Devices Market Dynamics
2.3.1 Continuous Glucose Monitoring Devices Industry Trends
2.3.2 Continuous Glucose Monitoring Devices Market Drivers
2.3.3 Continuous Glucose Monitoring Devices Market Challenges
2.3.4 Continuous Glucose Monitoring Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Continuous Glucose Monitoring Devices by Players
3.1.1 Global Continuous Glucose Monitoring Devices Revenue by Players (2019-2024)
3.1.2 Global Continuous Glucose Monitoring Devices Revenue Market Share by Players (2019-2024)
3.2 Global Continuous Glucose Monitoring Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Continuous Glucose Monitoring Devices, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Continuous Glucose Monitoring Devices Market Concentration Ratio
3.4.1 Global Continuous Glucose Monitoring Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Continuous Glucose Monitoring Devices Revenue in 2023
3.5 Global Key Players of Continuous Glucose Monitoring Devices Head office and Area Served
3.6 Global Key Players of Continuous Glucose Monitoring Devices, Product and Application
3.7 Global Key Players of Continuous Glucose Monitoring Devices, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Continuous Glucose Monitoring Devices Breakdown Data by Type
4.1 Global Continuous Glucose Monitoring Devices Historic Market Size by Type (2019-2024)
4.2 Global Continuous Glucose Monitoring Devices Forecasted Market Size by Type (2025-2030)
5 Continuous Glucose Monitoring Devices Breakdown Data by Application
5.1 Global Continuous Glucose Monitoring Devices Historic Market Size by Application (2019-2024)
5.2 Global Continuous Glucose Monitoring Devices Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Continuous Glucose Monitoring Devices Market Size (2019-2030)
6.2 North America Continuous Glucose Monitoring Devices Market Size by Type
6.2.1 North America Continuous Glucose Monitoring Devices Market Size by Type (2019-2024)
6.2.2 North America Continuous Glucose Monitoring Devices Market Size by Type (2025-2030)
6.2.3 North America Continuous Glucose Monitoring Devices Market Share by Type (2019-2030)
6.3 North America Continuous Glucose Monitoring Devices Market Size by Application
6.3.1 North America Continuous Glucose Monitoring Devices Market Size by Application (2019-2024)
6.3.2 North America Continuous Glucose Monitoring Devices Market Size by Application (2025-2030)
6.3.3 North America Continuous Glucose Monitoring Devices Market Share by Application (2019-2030)
6.4 North America Continuous Glucose Monitoring Devices Market Size by Country
6.4.1 North America Continuous Glucose Monitoring Devices Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Continuous Glucose Monitoring Devices Market Size by Country (2019-2024)
6.4.3 North America Continuous Glucose Monitoring Devices Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Continuous Glucose Monitoring Devices Market Size (2019-2030)
7.2 Europe Continuous Glucose Monitoring Devices Market Size by Type
7.2.1 Europe Continuous Glucose Monitoring Devices Market Size by Type (2019-2024)
7.2.2 Europe Continuous Glucose Monitoring Devices Market Size by Type (2025-2030)
7.2.3 Europe Continuous Glucose Monitoring Devices Market Share by Type (2019-2030)
7.3 Europe Continuous Glucose Monitoring Devices Market Size by Application
7.3.1 Europe Continuous Glucose Monitoring Devices Market Size by Application (2019-2024)
7.3.2 Europe Continuous Glucose Monitoring Devices Market Size by Application (2025-2030)
7.3.3 Europe Continuous Glucose Monitoring Devices Market Share by Application (2019-2030)
7.4 Europe Continuous Glucose Monitoring Devices Market Size by Country
7.4.1 Europe Continuous Glucose Monitoring Devices Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Continuous Glucose Monitoring Devices Market Size by Country (2019-2024)
7.4.3 Europe Continuous Glucose Monitoring Devices Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Continuous Glucose Monitoring Devices Market Size (2019-2030)
8.2 China Continuous Glucose Monitoring Devices Market Size by Type
8.2.1 China Continuous Glucose Monitoring Devices Market Size by Type (2019-2024)
8.2.2 China Continuous Glucose Monitoring Devices Market Size by Type (2025-2030)
8.2.3 China Continuous Glucose Monitoring Devices Market Share by Type (2019-2030)
8.3 China Continuous Glucose Monitoring Devices Market Size by Application
8.3.1 China Continuous Glucose Monitoring Devices Market Size by Application (2019-2024)
8.3.2 China Continuous Glucose Monitoring Devices Market Size by Application (2025-2030)
8.3.3 China Continuous Glucose Monitoring Devices Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Continuous Glucose Monitoring Devices Market Size (2019-2030)
9.2 Asia Continuous Glucose Monitoring Devices Market Size by Type
9.2.1 Asia Continuous Glucose Monitoring Devices Market Size by Type (2019-2024)
9.2.2 Asia Continuous Glucose Monitoring Devices Market Size by Type (2025-2030)
9.2.3 Asia Continuous Glucose Monitoring Devices Market Share by Type (2019-2030)
9.3 Asia Continuous Glucose Monitoring Devices Market Size by Application
9.3.1 Asia Continuous Glucose Monitoring Devices Market Size by Application (2019-2024)
9.3.2 Asia Continuous Glucose Monitoring Devices Market Size by Application (2025-2030)
9.3.3 Asia Continuous Glucose Monitoring Devices Market Share by Application (2019-2030)
9.4 Asia Continuous Glucose Monitoring Devices Market Size by Region
9.4.1 Asia Continuous Glucose Monitoring Devices Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Continuous Glucose Monitoring Devices Market Size by Region (2019-2024)
9.4.3 Asia Continuous Glucose Monitoring Devices Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Continuous Glucose Monitoring Devices Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Continuous Glucose Monitoring Devices Market Size by Type
10.2.1 Middle East, Africa, and Latin America Continuous Glucose Monitoring Devices Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Continuous Glucose Monitoring Devices Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Continuous Glucose Monitoring Devices Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Continuous Glucose Monitoring Devices Market Size by Application
10.3.1 Middle East, Africa, and Latin America Continuous Glucose Monitoring Devices Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Continuous Glucose Monitoring Devices Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Continuous Glucose Monitoring Devices Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Continuous Glucose Monitoring Devices Market Size by Country
10.4.1 Middle East, Africa, and Latin America Continuous Glucose Monitoring Devices Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Continuous Glucose Monitoring Devices Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Continuous Glucose Monitoring Devices Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Continuous Glucose Monitoring Devices Introduction
11.1.4 Abbott Laboratories Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.1.5 Abbott Laboratories Recent Developments
11.2 Echo Therapeutics, Inc.
11.2.1 Echo Therapeutics, Inc. Company Details
11.2.2 Echo Therapeutics, Inc. Business Overview
11.2.3 Echo Therapeutics, Inc. Continuous Glucose Monitoring Devices Introduction
11.2.4 Echo Therapeutics, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.2.5 Echo Therapeutics, Inc. Recent Developments
11.3 Dexcom, Inc.
11.3.1 Dexcom, Inc. Company Details
11.3.2 Dexcom, Inc. Business Overview
11.3.3 Dexcom, Inc. Continuous Glucose Monitoring Devices Introduction
11.3.4 Dexcom, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.3.5 Dexcom, Inc. Recent Developments
11.4 GlySens Incorporated
11.4.1 GlySens Incorporated Company Details
11.4.2 GlySens Incorporated Business Overview
11.4.3 GlySens Incorporated Continuous Glucose Monitoring Devices Introduction
11.4.4 GlySens Incorporated Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.4.5 GlySens Incorporated Recent Developments
11.5 Medtronic plc
11.5.1 Medtronic plc Company Details
11.5.2 Medtronic plc Business Overview
11.5.3 Medtronic plc Continuous Glucose Monitoring Devices Introduction
11.5.4 Medtronic plc Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.5.5 Medtronic plc Recent Developments
11.6 Senseonics Holdings, Inc.
11.6.1 Senseonics Holdings, Inc. Company Details
11.6.2 Senseonics Holdings, Inc. Business Overview
11.6.3 Senseonics Holdings, Inc. Continuous Glucose Monitoring Devices Introduction
11.6.4 Senseonics Holdings, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.6.5 Senseonics Holdings, Inc. Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Continuous Glucose Monitoring Devices Introduction
11.7.4 Johnson & Johnson Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.7.5 Johnson & Johnson Recent Developments
11.8 F. Hoffmann-La Roche Ltd.
11.8.1 F. Hoffmann-La Roche Ltd. Company Details
11.8.2 F. Hoffmann-La Roche Ltd. Business Overview
11.8.3 F. Hoffmann-La Roche Ltd. Continuous Glucose Monitoring Devices Introduction
11.8.4 F. Hoffmann-La Roche Ltd. Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.8.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.9 AgaMatrix, Inc.
11.9.1 AgaMatrix, Inc. Company Details
11.9.2 AgaMatrix, Inc. Business Overview
11.9.3 AgaMatrix, Inc. Continuous Glucose Monitoring Devices Introduction
11.9.4 AgaMatrix, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.9.5 AgaMatrix, Inc. Recent Developments
11.10 Glucovation
11.10.1 Glucovation Company Details
11.10.2 Glucovation Business Overview
11.10.3 Glucovation Continuous Glucose Monitoring Devices Introduction
11.10.4 Glucovation Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.10.5 Glucovation Recent Developments
11.11 GlySure
11.11.1 GlySure Company Details
11.11.2 GlySure Business Overview
11.11.3 GlySure Continuous Glucose Monitoring Devices Introduction
11.11.4 GlySure Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.11.5 GlySure Recent Developments
11.12 Arkray USA, Inc.
11.12.1 Arkray USA, Inc. Company Details
11.12.2 Arkray USA, Inc. Business Overview
11.12.3 Arkray USA, Inc. Continuous Glucose Monitoring Devices Introduction
11.12.4 Arkray USA, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.12.5 Arkray USA, Inc. Recent Developments
11.13 OrSense
11.13.1 OrSense Company Details
11.13.2 OrSense Business Overview
11.13.3 OrSense Continuous Glucose Monitoring Devices Introduction
11.13.4 OrSense Revenue in Continuous Glucose Monitoring Devices Business (2019-2024)
11.13.5 OrSense Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott Laboratories
Echo Therapeutics, Inc.
Dexcom, Inc.
GlySens Incorporated
Medtronic plc
Senseonics Holdings, Inc.
Johnson & Johnson
F. Hoffmann-La Roche Ltd.
AgaMatrix, Inc.
Glucovation
GlySure
Arkray USA, Inc.
OrSense
听
听
*If Applicable.
